United Therapeutics Corp
update 20:10
64.99
-0.68 (-1.04%%)
TODAY
High 65.97
Low 64.68
Open 65.75
Volume 442469
Time 20:10
52 WEEK SUMMARY
High 69.65
Low 44.51
P/E 12.27
Return
35.99%
Mkt Cap
3.261 B
United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously. United's products are currently in Phase III clinical trials.
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=464551764&utmp=%2Fquote%2FUTHR%3AUS&utmhn=10.248.179.13&utmac=UA-11413116-12&utmhid=639791846)